Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
PaperCitations, authors & open-access status
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 389 citations, 2023 year and closed oa status.
389
Citations
2023
Year
closed
OA Status